Becton Dickinson and (BDXB)
48.16
0.66 (1.39%)
At close: May 31, 2023, 8:00 PM
1.39% (1D)
| Bid | n/a |
| Market Cap | 13.69B |
| Revenue (ttm) | 20.64B |
| Net Income (ttm) | 1.73B |
| EPS (ttm) | 6.334 |
| PE Ratio (ttm) | 7.603410167350805 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 2,764,320 |
| Avg. Volume (20D) | 449,584 |
| Open | 47.20 |
| Previous Close | 47.50 |
| Day's Range | 47.65 - 48.82 |
| 52-Week Range | 45.85 - 52.52 |
| Beta | 0.56 |
About BDXB
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date May 21, 2020
Employees 77,000
Stock Exchange NYSE
Ticker Symbol BDXB
Website https://www.bd.com